GWP GW Pharm.

TIDMGWP

RNS Number : 9787K

GW Pharmaceuticals PLC

30 June 2014

 
 
 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES 
------------------------------------------------------------------------------------ 
 
 1. Identity of the issuer or the underlying           GW Pharmaceuticals Plc 
  issuer 
  of existing shares to which voting rights 
  are 
  attached: (ii) 
----------------------------------------------  ------------------------------------ 
 2 Reason for the notification (please tick the appropriate box or boxes): 
------------------------------------------------------------------------------------ 
 An acquisition or disposal of voting rights 
---------------------------------------------------------------------------  ------- 
 An acquisition or disposal of qualifying financial instruments 
  which may result in the acquisition of shares already issued to 
  which voting rights are attached 
---------------------------------------------------------------------------  ------- 
 An acquisition or disposal of instruments with similar economic 
  effect to qualifying financial instruments 
---------------------------------------------------------------------------  ------- 
 An event changing the breakdown of voting rights 
---------------------------------------------------------------------------  ------- 
 Other (please specify):                                                        X 
  Update to Total Voting Rights figure triggered this notification 
-----------------------------------------------------------------------      ------- 
 3. Full name of person(s) subject 
  to the 
  notification obligation: (iii)                    M&G Investment Funds (3) 
----------------------------------------  ------------------------------------------ 
 4. Full name of shareholder(s) 
  (if different from 3.):(iv) 
                                                 State Street Noms Ltd A/C GMIQ 
----------------------------------------  ------------------------------------------ 
 5. Date of the transaction and date                     26 June 2014 
  on 
  which the threshold is crossed 
  or 
  reached: (v) 
----------------------------------------  ------------------------------------------ 
 6. Date on which issuer notified:                       30 June 2014 
----------------------------------------  ------------------------------------------ 
 7. Threshold(s) that is/are crossed                      See item 13 
  or 
  reached: (vi, vii) 
----------------------------------------  ------------------------------------------ 
 
 
 
 8. Notified details: 
------------------------------------------------------------------------------------------------------------------------------ 
 A: Voting rights attached to shares (viii, ix) 
------------------------------------------------------------------------------------------------------------------------------ 
 Class/type     Situation previous                      Resulting situation after the triggering 
  of             to the triggering                       transaction 
  shares         transaction 
 
  if possible 
  using 
  the ISIN 
  CODE 
-------------  --------------------------------------  ----------------------------------------------------------------------- 
                Number           Number                 Number         Number of voting           % of voting rights 
                 of               of                     of shares      rights                     (x) 
                 Shares           Voting 
                                  Rights 
-------------  ---------------  ---------------------  -------------  -------------------------  ----------------------------- 
                                                        Direct         Direct          Indirect   Direct           Indirect 
                                                                        (xi)            (xii) 
-------------  ---  ---  -----     ------  -----  ---  -------------  --------------  ---------  ---------------  ------------ 
 GB0030544687     21,490,529          21,490,529         21,490,529     21,490,529        0           9.09%             0 
-------------  ---------------  ---------------------  -------------  --------------  ---------  ---------------  ------------ 
 US36197T1034      870,905            10,450,860          870,905       10,450,860        0           4.42%             0 
-------------  ---------------  ---------------------  -------------  --------------  ---------  ---------------  ------------ 
 B: Qualifying Financial Instruments 
------------------------------------------------------------------------------------------------------------------------------ 
 Resulting situation after the triggering transaction 
------------------------------------------------------------------------------------------------------------------------------ 
 Type of financial        Expiration        Exercise/                         Number of voting               % of voting 
  instrument               date (xiii)       Conversion Period                 rights that may                rights 
                                             (xiv)                             be 
                                                                               acquired if the 
                                                                               instrument is 
                                                                               exercised/ converted. 
-----------------------  ----------------  --------------------------------  -----------------------------  ------------------ 
 
 
 C: Financial Instruments with similar economic effect to Qualifying Financial 
  Instruments (xv, xvi) 
------------------------------------------------------------------------------------------------------------------------------ 
 Resulting situation after the triggering transaction 
------------------------------------------------------------------------------------------------------------------------------ 
 Type of financial   Exercise       Expiration     Exercise/           Number of voting                % of voting rights 
  instrument          price          date (xvii)    Conversion          rights instrument               (xix, xx) 
                                                    period              refers to 
                                                    (xviii) 
------------------  -------------  -------------  ------------------  ------------------------------  ------------------------ 
                                                                                                       Nominal        Delta 
------------------  -------------  -------------  ------------------  ------------------------------  -------------  --------- 
 
 
 Total (A+B+C) 
------------------------------------------------------------------------------------------------------------------------------ 
 Number of voting rights                                             Percentage of voting rights 
------------------------------------------------------------------  ---------------------------------------------------------- 
 31,941,389                                                          13.51% 
------------------------------------------------------------------  ---------------------------------------------------------- 
 
 
 
 9. Chain of controlled undertakings through which the voting rights and/or 
  the 
  financial instruments are effectively held, if applicable: (xxi) 
----------------------------------------------------------------------------------------- 
 
 
 Proxy Voting: 
----------------------------------------------------------------------------------------- 
 10. Name of the proxy holder:                                         N/A 
------------------------------------------------------  --------------------------------- 
 11. Number of voting rights proxy holder will                         N/A 
  cease 
  to hold: 
------------------------------------------------------  --------------------------------- 
 12. Date on which proxy holder will cease to                          N/A 
  hold 
  voting rights: 
------------------------------------------------------  --------------------------------- 
 
                                           With reference to item 3, M&G Investments 
  13. Additional information:               Funds (3) is an Open Ended Investment 
                                            Company (OEIC) and is not a Prudential 
                                            group company and must be separately 
                                            disclosed. 
                                            This OEIC Fund is managed by M&G Investment 
                                            Management Limited (a wholly owned 
                                            subsidiary of Prudential plc) and 
                                            will have been previously attributed 
                                            to Prudential plc solely on the basis 
                                            that M&G Investment Management Ltd 
                                            has direct fund management control 
                                            over the shares identified in this 
                                            notification. 
 
                                            Therefore the 13.51% holding being 
                                            disclosed in this notification is 
                                            encompassed in the 13.51% being disclosed 
                                            under The Prudential plc group of 
                                            companies and is NOT in addition to 
                                            it. 
----------------------------------------  ----------------------------------------------- 
 14. Contact name:                         Owen Smith / James Todd 
                                            M&G Investment Management Limited 
----------------------------------------  ----------------------------------------------- 
 15. Contact telephone number:             020 7004 4517 / 020 7548 2293 
----------------------------------------  ----------------------------------------------- 
 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLEAKKEDFALEFF

Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Jun 2024 to Jul 2024

Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Jul 2023 to Jul 2024